Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 2/20 | 0.49 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | SNCA | P37840 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | METAP2 | P50579 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6169064 | 1.00 | KEAP1 (0.49) | KEAP1NFE2L2KDM4ESNCANPSR1 | |
| SCHEMBL6170402 | 0.88 | METAP2 (0.57) | KEAP1NFE2L2SNCAMETAP2ALDH1A1 | |
| SCHEMBL6170396 | 0.88 | METAP2 (0.57) | KEAP1NFE2L2SNCAMETAP2ALDH1A1 | |
| SCHEMBL7488003 | 0.87 | KEAP1 (0.53) | KEAP1NFE2L2NPSR1METAP2ALDH1A1 | |
| SCHEMBL7488011 | 0.87 | KEAP1 (0.53) | KEAP1NFE2L2NPSR1METAP2ALDH1A1 | |
| SCHEMBL6170538 | 0.87 | ERBB2 (0.55) | KEAP1NFE2L2KDM4ESNCAMETAP2 | |
| SCHEMBL6170544 | 0.87 | ERBB2 (0.55) | KEAP1NFE2L2KDM4ESNCAMETAP2 | |
| SCHEMBL6171419 | 0.87 | KEAP1 (0.59) | KEAP1NFE2L2SNCAALDH1A1KMT2A | |
| SCHEMBL6171415 | 0.87 | KEAP1 (0.59) | KEAP1NFE2L2SNCAALDH1A1KMT2A | |
| SCHEMBL6169480 | 0.86 | KDM1A (0.48) | KEAP1NFE2L2SNCAMETAP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045833-B1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6608070-B1 | Useful for treatment of medical condition in which prostaglandins are implicated as pathogens | NAKAO KAZUNARI (JP) | 2003-08-19 | — | — | US | disclosed |
| EP-1065206-B1 | Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents | PFIZER (US) | 2002-10-09 | — | — | EP | disclosed |
| EP-1065206-A1 | Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents | PFIZER INC. (US) | 2001-01-03 | — | — | EP | disclosed |